Gts Securities LLC Amylyx Pharmaceuticals, Inc. Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$1.65 - $3.24 $12,705 - $24,948	7,700 Added 46.11%	24,400 $79,000
Q2 2024 Aug 14, 2024	SELL	$1.62 - $2.71 $283,338 - $473,979	-174,900 Reduced 91.28%	16,700 $31,000
Q1 2024 May 15, 2024	BUY	$2.71 - $19.57 $478,315 - $3.45 Million	176,500 Added 1168.87%	191,600 $544,000
Q4 2023 Feb 14, 2024	BUY	$12.07 - $18.46 $53,108 - $81,224	4,400 Added 41.12%	15,100 $222,000
Q3 2023 Nov 15, 2023	BUY	$18.08 - $23.45 $193,455 - $250,915	10,700 New	10,700 $195,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $290M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.